Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with B2M and STK11 mutations: a case report.
Sign Up to like & getrecommendations! Published in 2020 at "Immunotherapy"
DOI: 10.2217/imt-2019-0166
Abstract: Lung large-cell neuroendocrine carcinoma (LCNEC) is a rare tumor with poor prognosis. Despite the increasing prevalence of immune checkpoint inhibitors (ICIs) across a broad spectrum of solid tumors, very limited information is available about the… read more here.
Keywords: lung large; cell neuroendocrine; large cell; neuroendocrine carcinoma ... See more keywords
The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1050800
Abstract: Lung large cell neuroendocrine carcinoma (LCNEC) is a rare and highly aggressive malignancy with a dismal prognosis. This study was designed to depict patterns of distant organ metastatic and to analyze prognosis of LCNEC patients.… read more here.
Keywords: lung large; prognosis; large cell; neuroendocrine carcinoma ... See more keywords